SGX Market Updates

Highlights of Singapore’s Healthcare Services Stocks


PUBLISHED ON |

05 March 2019

  • In the first 2 months of 2019, the 5 best-performing healthcare service providers were: ISEC Healthcare (+11.8%), Thomson Medical (+9.5%), Singapore Medical Group (+8.7%), Medinex (+5.6%), and Asian Healthcare Specialists (+5.4%). They averaged a total return of +8.2% over the period.

  • The combined trading turnover for the 5 largest capitalised healthcare service providers rose 26% to an average S$3.5 million per day in Feb, from S$2.8 million per day in the preceding three months. Thomson Medical and Raffles Medical saw the largest increases in average daily traded values.

  • Healthcare was a net buy sector for retail investors for the second straight month in Feb, drawing net inflows of about S$6.5 million, after net inflows of S$20.5 million in Jan. This reverses a net retail outflow of S$54.8 million for the sector in calendar year 2018, SGX data showed.




There are 18 healthcare service providers listed on SGX that operate patient care services and facilities in Singapore and worldwide. These facilities include laboratories, hospitals, nursing homes and clinics that offer services and treatments ranging from family medicine, dentistry, endoscopy and aesthetics to gynaecology, oncology, paediatrics, orthopaedics, ophthalmology and even cord blood banking.

4 healthcare service providers that listed on SGX over the last two years were: Medinex Ltd (December 2018), Asian Healthcare Specialists (April 2018), Clearbridge Health (December 2017), and Aoxin Q & M Dental (April 2017).



Healthcare Index Clocks Nearly 10% YTD Total Return

The performance of Singapore’s listed healthcare sector is measured by the iEdge SG All Healthcare Index, which is a free-float, market capitalisation-weighted index comprising 31 stocks. Healthcare service providers are well-represented in the Index, accounting for more than half its constituents.

In the first two months of 2019, the Index generated a total return of 9.7%. This compares with total returns of 4.8% and 5.4% respectively for the benchmark Straits Times Index (STI) and the broader FTSE ST All-Share Index over the same period.


Jan-Feb 2019 Total Returns

Source: Bloomberg



Best-Performing Healthcare Services Stocks in Jan-Feb 2019

In the first two months of 2019, the five best-performing healthcare service providers were: ISEC Healthcare (+11.8%), Thomson Medical Group (+9.5%), Singapore Medical Group (+8.7%), Medinex Ltd (+5.6%), and Asian Healthcare Specialists (+5.4%). These five stocks averaged a total return of +8.2% over the period, bringing their one-year and three-year total returns to -12.2% and +31.1% respectively.

The table below details the 18 healthcare service providers listed on SGX, sorted by YTD total return.

Name SGX
Code
Market
Cap
S$m
Total
Return
YTD
(%)
Total
Return
1Y
(%)
Total
Return
3Y
(%)
Total
Return
2018
(%)
Total
Return
2017
(%)
ISEC HEALTHCARE 40T 147 11.8 -7.8 26.7 -14.9 8.9
THOMSON MEDICAL GROUP A50 2,087 9.5 -31.0 -42.9 -41.9 4.9
SINGAPORE MEDICAL GROUP 5OT 206 8.7 -22.3 171.9 -30.4 32.2
MEDINEX LTD OTX 37.4 5.6 NA NA NA NA
ASIAN HEALTHCARE SPECIALISTS 1J3 88.0 5.4 NA NA NA NA
ASIAMEDIC LTD 505 8.6 4.8 -63.3 -66.7 -66.1 -7.5
IHH HEALTHCARE Q0F 16,223 3.4 -7.5 -12.3 -7.3 -8.9
CORDLIFE GROUP P8A 98.8 2.6 -48.6 -72.0 -51.2 -18.9
CLEARBRIDGE HEALTH 1H3 83.2 1.8 -68.8 NA -53.0 NA
HEALTH MGMT INTL 588 456 1.5 -12.4 84.3 -17.2 4.1
SINGAPORE O&G 1D8 167 0.0 -2.2 3.1 -16.6 -23.2
RAFFLES MEDICAL GROUP BSL 1,977 0.0 -2.4 -20.6 0.2 -20.5
HC SURGICAL SPECIALISTS 1B1 87 -1.7 -11.2 NA -10.9 18.5
Q&M DENTAL QC7 373 -5.0 -23.5 -29.8 -16.8 -12.2
OUE LIPPO HEALTHCARE 5WA 271 -6.2 -50.2 22.3 -40.6 150.0
TALKMED GROUP 5G3 736 -6.7 -15.0 40.0 -9.0 36.6
HEALTHWAY MEDICAL GROUP 5NG 131 -9.4 -43.1 3.6 -40.7 63.6
AOXIN Q&M DENTAL 1D4 76.3 -13.0 0.9 NA 10.5 NA
Average   0.7 -22.7 6.0 -22.5 12.6

Source: StockFacts & Bloomberg (data as of 28 Feb 2019)



Five Largest Capitalised Healthcare Providers on SGX

The five largest capitalised healthcare service providers on SGX are: IHH Healthcare, Thomson Medical Group, Raffles Medical Group, Talkmed Group, and Health Management International (HMI). These five stocks, with a combined market capitalisation of over S$20 billion, have averaged a total return of +1.6% in the first two months of this year. This brings their one-year and three-year total returns to -13.7% and +9.7% respectively.

For the month of February 2019, the combined trading turnover for these five largest capitalised healthcare service providers rose by 26% to an average S$3.5 million per day, from an average S$2.8 million per day in the preceding three months. In particular, three of the five largest capitalised healthcare service providers saw higher average daily trading values in February, compared to the previous three months. They were Thomson Medical Group (+52.9%), Raffles Medical Group (+3.0%), and HMI (+1.6%).



Net Buy Sector for Retail Investors

Healthcare was a net buy sector for retail investors for the second straight month in February, drawing inflows of about S$6.5 million, following net inflows of S$20.5 million in January. This reverses a net retail outflow of S$54.8 million for the sector in calendar year 2018, SGX data showed.

For institutional investors, Healthcare was a net sell for the second straight month in February, with net outflows of S$7.9 million, after a net outflow of S$21.5 million in January. This reverses a net institutional inflow of S$49.4 million for the sector in calendar year 2018, according to SGX data.


Healthcare Stocks Fund Flow

Source: SGX data



Defensive With Robust Prospects

Singapore’s healthcare sector is typically viewed as a defensive segment, poised to enjoy multi-year growth prospects. Drivers of Asia’s increased healthcare spending levels include accelerated ageing rates, the rise of lifestyle diseases like diabetes and hypertension, as well as growing disposable incomes. 

The majority of Singapore’s healthcare service providers have also pursued international expansion plans in recent years. Their operations and assets span multiple geographies outside Singapore, including markets in South and Southeast Asia, Northeast Asia, as well as Middle East and Europe.

Investors can easily participate in the structural Asian healthcare theme through SGX-listed healthcare stocks that are rapidly expanding into regional and global markets to meet growing patient needs.







This article is provided by SGX My Gateway.



SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the SGX Group Companies) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.












Stock / REIT Search

Advertisement

Advertisement